(Q34501780)

English

Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

Kevin Yarasheski

1

object named as

Kevin E Yarasheski

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dominic N. Reeds

9

object named as

Dominic N Reeds

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

W Todd Cade

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

E Turner Overton

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Kristin E Mondy

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sara Hubert

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Erin Laciny

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Coco Bopp

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sherry Lassa-Claxton

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

19 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

300

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

E243-51

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Rosiglitazone improves lipoatrophy in patients receiving thymidine-sparing regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Cardiovascular disease and HIV infection: host, virus, or drugs?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Trends in mortality and causes of death among women with HIV in the United States: a 10-year study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Impact of lipoatrophy on quality of life in HIV patients receiving anti-retroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

The prevention of type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Magnetic resonance imaging for quantifying regional adipose tissue in human immunodeficiency virus-infected persons with the cardiometabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Adiponectin and cardiovascular disease: state of the art?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

PPARalpha activation elevates blood pressure and does not correct glucocorticoid-induced insulin resistance in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Estimating the proportion of patients infected with HIV who will die of comorbid diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

7 July 2018

Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Evaluation of safety and efficacy of rosiglitazone in the treatment of HIV-associated lipodystrophy syndrome.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: a 2 x 2 factorial, randomized, double-blinded, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Ten-year predicted coronary heart disease risk in HIV-infected men and women.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Effect of rosiglitazone on peroxisome proliferator-activated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Revisiting the rosiglitazone story--lessons learned

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART).

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Visceral adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemia.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

27 October 2018

Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

27 October 2018

Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3023206

27 October 2018

Low-intensity exercise increases skeletal muscle protein expression of PPARδ and UCP3 in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00468.2010

21 January 2018

Use of thiazolidinediones in HIV-infected patients: what have we learned?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20959530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20959530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exercise Training for Type 2 Diabetes Mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20959530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1152/AJPENDO.00468.2010

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34501780&oldid=2082207644"